Mark J Macielag (Mark Macielag)

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Guozhang Xu, Zhijie Liu, Xinkang Wang, Tianbao Lu, Renee L DesJarlais, Tho Thieu, Jing Zhang, Zheng Huang Devine, Fuyong Du, Qiu Li, Cynthia M Milligan, Paul Shaffer, Peder E Cedervall, John C Spurlino, Christopher F Stratton, Beth Pietrak, Lawrence M Szewczuk, Victoria Wong, Ruth A Steele, Wouter Bruinzeel, Madhu Chintala, Jose Silva, Michael D Gaul, Mark J Macielag, Ravi Nargund
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions. Journal of medicinal chemistry 65 (15) (2022)
Bin Zhu, Xuqing Zhang, Lili Guo, Matthew Rankin, Ivona Bakaj, George Ho, Seunghun P Lee, Lisa Norquay, Mark J Macielag
Discovery and Optimization of 7-Alkylidenyltetrahydroindazole-Based Acylsulfonamide EP3 Antagonists. ACS medicinal chemistry letters 13 (1) (2021)

Mark J Macielag.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Macielag)